PAPER Zhang C, Ye Y, Wang W, Wang C, Gao P, Wan P

Effects of Lingzhi or Reishi Medicinal Mushroom Ganoderma lucidum (Agaricomycetes) Triterpene on Motor and Spatial Learning Disorders in 5xFAD Mice.

Int J Med Mushrooms. 2025;27(4):21-37. PubMed.

PAPER Wan Z, Ma T

The impact of apolipoprotein E, type ∊4 allele on Alzheimer's disease pathological biomarkers: a comprehensive post-mortem pilot-analysis.

PLoS One. 2025;20(2):e0303486. Epub 2025 Feb 6 PubMed.

PAPER Guo R, Li D, Li F, Ji L, Liu H, Qiao H, Lv Z, Tang Y, Wang D

Effects of whole-head 810 nm near-infrared therapy on cognitive and neuropsychiatric symptoms in Alzheimer's disease: A pilot study.

J Alzheimers Dis. 2025 Feb 5;:13872877251313819. Epub 2025 Feb 5 PubMed.

PAPER Ma Q, Tian JL, Lou Y, Guo R, Ma XR, Wu JB, Yang J, Tang BJ, Li S, Qiu M, Duan S, Zhao JW, Zhang J, Xu ZZ

Oligodendrocytes drive neuroinflammation and neurodegeneration in Parkinson's disease via the prosaposin-GPR37-IL-6 axis.

Cell Rep. 2025 Feb 4;44(2):115266. Epub 2025 Feb 4 PubMed.

PAPER Coleman PD, Delvaux E, Kordower JH, Boehringer A, Huseby CJ

Massive changes in gene expression and their cause(s) can be a unifying principle in the pathobiology of Alzheimer's disease.

Alzheimers Dement. 2025 Feb 6;:e14555. Epub 2025 Feb 6 PubMed.

PAPER Almutairi JA

Alzheimer's disease: assessing the therapeutic potential of anti-Aβ (Beta-Amyloid) treatments.

Cell Mol Biol (Noisy-le-grand). 2025 Feb 2;71(1):111-117. PubMed.

PAPER Li J, Liu C, Ang TF, Au R

Associations of Mid- and Late-Life Fasting Blood Glucose Levels With Dementia Risk Among Patients With Diabetes: Framingham Heart Study.

Eur J Neurol. 2025 Feb;32(2):e70062. PubMed.

PAPER Bergmann C, Mousaei K, Rizzoli SO, Tchumatchenko T

How energy determines spatial localisation and copy number of molecules in neurons.

Nat Commun. 2025 Feb 7;16(1):1424. PubMed.

PAPER Huang Q

The U.S dementia belt: Commentary on "Alzheimer's disease and related dementia among Medicare beneficiaries aged ≥ 65 years in rural America, by census region and select demographic characteristics: 2020".

J Rural Health. 2025 Jan;41(1):e70000. PubMed.

PAPER Thomas EV, Han C, Kim WJ, Asress S, Li Y, Taylor JA, Gearing M, Fournier CN, McEachin ZT, Seyfried NT, Glass JD

ALS plasma biomarkers reveal neurofilament and pTau correlate with disease onset and progression.

Ann Clin Transl Neurol. 2025 Feb 6; Epub 2025 Feb 6 PubMed.

PAPER Faheem MS, Khan AA, Nawaz M

Advances in the management of Alzheimer's disease.

Neurodegener Dis Manag. 2025 Feb 6;:1-3. Epub 2025 Feb 6 PubMed.

PAPER Baiardi S, Parchi P

Perspectives Toward the Development of Quantitative Seed Amplification Assays for α-Synuclein.

Neurology. 2025 Mar 11;104(5):e213384. Epub 2025 Feb 6 PubMed.

PAPER Coughlin DG, Shifflett B, Farris CM, Ma Y, Galasko D, Edland SD, Mollenhauer B, Brumm MC, Poston KL, Marek K, Siderowf AD, Soto C, Concha-Marambio L, as the Investigators of the Parkinson's Progression Marker Initiative

α-Synuclein Seed Amplification Assay Amplification Parameters and the Risk of Progression in Prodromal Parkinson Disease.

Neurology. 2025 Mar 11;104(5):e210279. Epub 2025 Feb 6 PubMed.

PAPER Chemla A, Arena G, Sacripanti G, Barmpa K, Zagare A, Garcia P, Gorgogietas V, Antony P, Ohnmacht J, Baron A, Jung J, Lind-Holm Mogensen F, Michelucci A, Marzesco AM, Buttini M, Schmidt T, Grünewald A, Schwamborn JC, Krüger R, Saraiva C

Parkinson's disease mutant Miro1 causes mitochondrial dysfunction and dopaminergic neuron loss.

Brain. 2025 Feb 6; Epub 2025 Feb 6 PubMed.

PAPER Mielke MM, Evans JK, Neiberg RH, Molina-Henry DP, Marcovina SM, Johnson KC, Carmichael OT, Rapp SR, Sachs BC, Ding J, Shappell HM, Luchsinger JA, Espeland MA, Hayden KM

Alzheimer Disease Blood Biomarkers and Cognition Among Individuals With Diabetes and Overweight or Obesity.

JAMA Netw Open. 2025 Feb 3;8(2):e2458149. PubMed.